301206.SZ
三元生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 23.58
−1.50%Year over year
Reported trailing growth
- Revenue
- +7.9%
- EBITDA
- —
- EBIT
- -18.3%
- EPS
- -10.7%
- Free cash flow
- -4.5%
- Operating cash flow
- +794.5%
Forward estimates
Based on analyst estimates
- Revenue
- +10.0%
- EBITDA
- +231.5%
- EPS
- +358.6%
Three-year CAGR
- Revenue
- -1.3%
- EBITDA
- -7.4%
- EBIT
- -17.4%
- Net income
- -17.7%
- EPS
- -17.5%
- Free cash flow
- -13.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026